SHONTAE HOWARD: Open Payments
NPI 1255531315 · ENGLEWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,251 in 111 payments from 17 companies in 2025. Trend: 2023 $169 · 2024 $361 · 2025 $2,251
Food & beverage: $2,251
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $388 |
| Vanda Pharmaceuticals Inc. | 10 | $302 |
| ABBVIE INC. | 12 | $280 |
| Alkermes, Inc. | 11 | $231 |
| Lundbeck LLC | 16 | $203 |
| Teva Pharmaceuticals USA, Inc. | 12 | $195 |
| E.R. Squibb & Sons, L.L.C. | 2 | $138 |
| Janssen Pharmaceuticals, Inc | 5 | $105 |
| Indivior Inc. | 5 | $103 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
Products named: REXULTI, VRAYLAR, ARISTADA, HETLIOZ, COBENFY, AUSTEDO XR, FANAPT, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
